ABT Stock - Abbott Laboratories

ABT Stock Chart

ABT Profile

Abbott Laboratories, along with its subsidiaries, is a global leader in healthcare product discovery, development, manufacturing, and distribution. The company operates across four distinct segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Within the Established Pharmaceutical Products segment, Abbott offers a broad range of generic pharmaceuticals addressing conditions such as pancreatic exocrine insufficiency, hypertension, pain management, and various infectious diseases. This segment also includes products like hormone replacement therapy and treatments for dyslipidemia and Menière's disease.

In the Diagnostic Products sector, Abbott Laboratories provides comprehensive laboratory and molecular diagnostics systems. These systems cover immunoassay, clinical chemistry, hematology, and transfusion medicine, alongside molecular diagnostics that automate DNA and RNA analysis, aiding in the detection of infectious agents and genetic disorders. Abbott's portfolio further extends to rapid diagnostics, point-of-care testing for diseases like HIV and influenza, as well as cardiometabolic and drug/alcohol testing solutions. Additionally, the company offers informatics and automation solutions that optimize laboratory operations.

Abbott's Nutritional Products division specializes in pediatric and adult nutritional supplements, catering to a wide range of dietary needs. Meanwhile, in the Medical Devices segment, Abbott delivers advanced technologies for cardiovascular diseases, including rhythm management devices, electrophysiology solutions, heart failure treatments, vascular interventions, and structural heart therapies. The segment also encompasses diabetes care products and neuromodulation devices designed to manage chronic pain and movement disorders. Established in 1888 and headquartered in North Chicago, Illinois, Abbott Laboratories continues to innovate across its diverse portfolio, enhancing healthcare outcomes worldwide through its commitment to research, technology, and patient-centric solutions.

ABT Revenue Chart

ABT Earnings

Analyst Ratings